CTL recognition of a bulged viral peptide involves biased TCR selection

Journal of Immunology

Volumn 175, Issue 6, 2005, Pages 3826-3834

  Miles, John J ^a,b   Elhassen, Diah ^c   Borg, Natalie A ^d   Silins, Sharon L ^a   Tynan, Fleur E ^d   Burrows, Jacqueline M ^a   Purcell, Anthony W ^c   Kjer Nielsen, Lars ^c   Rossjohn, Jamie ^d   Burrows, Scott R ^a   McCluskey, James ^c  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; BIODIVERSITY; CLONOGENESIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOGENICITY; LIGAND BINDING; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN MOTIF; SEQUENCE ANALYSIS; T LYMPHOCYTE ACTIVATION;

EID: 24744457740     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.6.3826     Document Type: Article

References (57)

1. Arstila, T. P., A. Casrouge, V. Baron, J. Even, J. Kanellopoulos, and P. Kourilsky. 1999. A direct estimate of the human αβ T cell receptor diversity. Science 286: 958-961.
2. Davis, M. M., and P. J. Bjorkman. 1988. T-cell antigen receptor genes and T-cell recognition. Nature 334: 395-402.
3. + T-cell repertoire directed against an influenza peptide: a step towards TCR proteomics. Immunogenetics 54: 611-620.
4. + T cell clones following immune reconstitution on highly active antiretroviral therapy. J. Immunol. 170: 1106-1116.
5. Garcia, K. C., L. Teyton, and I. A. Wilson. 1999. Structural basis of T cell recognition. Annu. Rev. Immunol. 17: 369-397.
6. Rammensee, H. G., K. Falk, and O. Rotzschke. 1993. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11: 213-244.
7. Rudolph, M. G., and I. A. Wilson. 2002. The specificity of TCR/pMHC interaction. Curr. Opin. Immunol. 14: 52-65.
8. Urban, R. G., R. M. Chicz, W. S. Lane, J. L. Strominger, A. Rehm, M. J. Kenter, F. G. UytdeHaag, H. Ploegh, B. Uchanska-Ziegler, and A. Ziegler. 1994. A. subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc. Natl. Acad. Sci. USA 91: 1534-1538.
9. Green, K. J., J. J. Miles, J. Tellam, W. J. van Zuylen, G. Connolly, and S. R. Burrows. 2004. Potent T cell response to a class I-binding 13-mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length. Eur. J. Immunol. 34: 2510-2519.
10. Khanna, R., and S. R. Burrows. 2000. Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases. Annu. Rev. Microbiol. 54: 19-48.
11. Probst-Kepper, M., V. Stroobant, R. Kridel, B. Gaugler, C. Landry, F. Brasseur, J. P. Cosyns, B. Weynand, T. Boon, and B. J. Van Den Eynde. 2001. An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes. J. Exp. Med 193: 1189-1198.
12. Lim, A., L. Trautmann, M. A. Peyrat, C. Couedel, F. Davodeau, F. Romagne, P. Kourilsky, and M. Bonneville. 2000. Frequent contribution of T cell clono-types with public TCR features to the chronic response against a dominant EBV-derived epitope: application to direct detection of their molecular imprint on the human peripheral T cell repertoire. J. Immunol. 165: 2001-2011.
13. Speir, J. A., J. Stevens, E. Joly, G. W. Butcher, and I. A. Wilson. 2001. Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa. Immunity 14: 81-92.
14. Probst-Kepper, M., H. J. Hecht, H. Herrmann, V. Janke, F. Ocklenburg, J. Klempnauer, B. J. van den Eynde, and S. Weiss. 2004. Conformational restraints and flexibility of 14-meric peptides in complex with HLA-B*3501. J. Immunol. 173: 5610-5616.
15. Collins, E. J., D. N. Garboczi, and D. C. Wiley. 1994. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature 371: 626-629.
16. Stryhn, A., L. O. Pedersen, A. Holm, and S. Buus. 2000. Longer peptide can be accommodated in the MHC class I binding site by a protrusion mechanism. Eur. J. Immunol. 30: 3089-3099.
17. bheterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria. J. Immunol. 163: 4434-4441.
18. Guo, H. C., T. S. Jardetzky, T. P. Garrett, W. S. Lane, J. L. Strominger, and D. C. Wiley. 1992. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 360: 364-366.
19. Garboczi, D. N., and W. E. Biddison. 1999. Shapes of MHC restriction. Immunity 10: 1-7.
20. Khanna, R., S. R. Burrows, and D. J. Moss. 1995. Immune regulation in Epstein-Barr virus-associated diseases. Microbiol. Rev. 59: 387-405.
21. Burrows, S. R., S. L. Silins, D. J. Moss, R. Khanna, I. S. Misko, and V. P. Argaet. 1995. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J. Exp. Med. 182: 1703-1715.
22. Panzara, M. A., E. Gussoni, L. Steinman, and J. R. Oksenberg. 1992. Analysis of the T cell repertoire using the PCR and specific oligonucleotide primers. BioTechniques 12: 728-735.
23. Lefranc, M. P. 2001. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 29: 207-209.
24. Chothia, C., D. R. Boswell, and A. M. Lesk. 1988. The outline structure of the T-cell αβ receptor. EMBO J. 7: 3745-3755.
25. Salter, R. D., and P. Cresswell. 1986. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J. 5: 943-949.
26. Clements, C. S., L. Kjer-Nielsen, A. G. Brooks, A. W. Purcell, J. McCluskey, and J. Rossjohn. 2002. The production, purification and crystallisation of a soluble, heterodimeric form of a highly selected T-cell receptor in its unliganded and liganded state. Acta Crystallogr. D 58: 2131-2134.
27. Macdonald, W., D. S. Williams, C. S. Clements, J. J. Gorman, L. Kjer-Nielsen, A. G. Brooks, J. McCluskey, J. Rossjohn, and A. W. Purcell. 2002. Identification of a dominant self-ligand bound to three HLA B44 alleles and the preliminary crystallographic analysis of recombinant forms of each complex. FEBS Lett. 527: 27-32.
28. Rossmann, M. G., and C. G. van Beek. 1999. Data processing. Acta Crystallogr. D 55: 1631-1640.
29. Jones, T. A., J. Y. Zou, S. W. Cowan, and Kjeldgaard. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47: 110-119.
30. Brunger, A. T., P. D. Adams, G. M. Clore, W. L. DeLano, P. Gros, R. W. Grosse-Kunstleve, J. S. Jiang, J. Kuszewski, M. Nilges, N. S. Pannu, et al. 1998. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54: 905-921.
31. Saulquin, X., C. Ibisch, M. A. Peyrat, E. Scotet, M. Hourmant, H. Vie, M. Bonneville, and E. Houssaint. 2000. A global appraisal of immunodominant CD8 T cell responses to Epstein-Barr virus and cytomegalovirus by bulk screening. Eur. J. Immunol. 30: 2531-2539.
32. Lefranc, M. P. 2003. IMGT databases, web resources and tools for immunoglobulin and T cell receptor sequence analysis, http://imgt.cines.fr. Leukemia 17: 260-266.
33. Falk, K., O. Rotzschke, B. Grahovac, D. Schendel, S. Stevanovic, G. Jung, and H. G. Rammensee. 1993. Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics 38: 161-162.
34. Smith, K. J., S. W. Reid, D. I. Stuart, A. J. McMichael, E. Y. Jones, and J. I. Bell. 1996. An altered position of the a 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity 4: 203-213.
35. Menssen, R., P. Orth, A. Ziegler, and W. Saenger. 1999. Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus. J. Mol. Biol. 285: 645-653.
36. Saper, M. A., P. J. Bjorkman, and D. C. Wiley. 1991. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J. Mol. Biol. 219: 277-319.
37. Garrett, T. P., M. A. Saper, P. J. Bjorkman, J. L. Strominger, and D. C. Wiley. 1989. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 342: 692-696.
38. Schonbach, C., K. Miwa, M. Ibe, H. Shiga, K. Nokihara, and M. Takiguchi. 1996. Refined peptide HLA-B*3501 binding motif reveals differences in 9-mer to 11-mer peptide binding. Immunogenetics 45: 121-129.
39. bm8 complexed to a herpes simplex virus determinant: evidence for a conformational switch that governs T cell repertoire selection and viral resistance. J. Immunol. 173: 402-409.
40. Messaoudi, I., J. A. Patino, R. Dyall, J. LeMaoult, and J. Nikolich-Zugich. 2002. Direct link between MHC polymorphism, T cell avidity, and diversity in immune defense. Science 298: 1797-1800.
41. Hofmann, M., M. Radsak, G. Rechtsteiner, K. Wiemann, M. Gunder, U. Bien-Grater, R. Offringa, R. E. Toes, H. G. Rammensee, and H. Schild. 2004. T cell avidity determines the level of CTL activation. Eur. J. Immunol. 34: 1798-1806.
42. Meyer-Olson, D., N. H. Shoukry, K. W. Brady, H. Kim, D. P. Olson, K. Hartman, A. K. Shintani, C. M. Walker, and S. A. Kalams. 2004. Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J. Exp. Med. 200: 307-319.
43. Kalams, S. A., R. P. Johnson, A. K. Trocha, M. J. Dynan, H. S. Ngo, R. T. D'Aquila, J. T. Kurnick, and B. D. Walker. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179: 1261-1271.
44. Argaet, V. P., C. W. Schmidt, S. R. Burrows, S. L. Silins, M. G. Kurilla, D. L. Doolan, A. Suhrbier, D. J. Moss, E. Kieff, T. B. Suclley, et al. 1994. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J. Exp. Med. 180: 2335-2340.
45. Mongkolsapaya, J., A. Jaye, M. F. Callan, A. F. Magnusen, A. J. McMichael, and H. C. Whittle. 1999. Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection. J. Virol 73: 67-71.
46. Kedzierska, K., S. J. Turner, and P. C. Doherty. 2004. Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope. Proc. Natl. Acad. Sci. USA 101: 4942-4947.
47. Lehner, P. J., E. C. Wang, P. A. Moss, S. Williams, K. Platt, S. M. Friedman, J. I. Bell, and L. K. Borysiewicz. 1995. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the Vβ17 gene segment. J. Exp. Med. 181: 79-91.
48. Su, C., and M. Nei. 2001. Evolutionary dynamics of the T-cell receptor VB gene family as inferred from the human and mouse genomic sequences. Mol. Biol. Evol. 18: 503-513.
49. Infante, A. J., J. Baillargeon, E. Kraig, L. Lott, C. Jackson, G. J. Hammerling, R. Raju, and C. David. 2003. Evidence of a diverse T cell receptor repertoire for acetylcholine receptor, the autoantigen of myasthenia gravis. J. Autoimmun. 21: 167-174.
50. + T cells that are specific for certain viral epitopes. Arthritis. Res. 2: 154-164.
51. Scotet, E., M. A. Peyrat, X. Saulquin, C. Retiere, C. Couedel, F. Davodeau, N. Dulphy, A. Toubert, J. D. Bignon, A. Lim, et al. 1999. Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. Eur. J. Immunol. 29: 973-985.
52. Kjer-Nielsen, L., C. S. Clements, A. G. Brooks, A. W. Purcell, J. McCluskey, and J. Rossjohn. 2002. The 1.5 Å crystal structure of a highly selected antiviral T cell receptor provides evidence for a structural basis of immunodominance. Structure 10: 1521-1532.
53. Kjer-Nielsen, L., C. S. Clements, A. W. Purcell, A. G. Brooks, J. C. Whisstock, S. R. Burrows, J. McCluskey, and J. Rossjohn. 2003. A structural basis for the selection of dominant alphaβ T cell receptors in antiviral immunity. Immunity 18: 53-64.
54. Davis, M. M. 2003. The problem of plain vanilla peptides. Nat. Immunol. 4: 649-650.
55. Stewart-Jones, G. B., A. J. McMichael, J. I. Bell, D. I. Stuart, and E. Y. Jones. 2003. A structural basis for immunodominant human T cell receptor recognition. Nat. Immunol. 4: 657-663.
56. Tynan, F. E., N. A. Borg, J. J. Miles, T. Beddoe, D. El-Hassen, S. L. Silins, W. J. van Zuylen, A. W. Purcell, L. Kjer-Nielsen, J. McCluskey, et al. 2005. The high resolution structures of highly bulged viral epitopes bound to the major histocompatibility class I: implications for T-cell receptor engagement and T-cell immunodominance. J. Biol. Chem. 280: 23900-23909.
57. + T populations. Nat. Immunol. 6: 382-389.